Page 26 - Vaccine

NEGVAC in talks with offshore manufacturers for import of Covid jabs: Govt

In a written reply to a question in the Rajya Sabha, MoS for Health Bharati Pravin Pawar said as on July 16, a total of 2.61 lakh doses of the Sputnik V vaccine have been administered in the country

TechInvention ties up with Korean co to bring oral cholera vaccine to India

Clinical trials of WHO pre-qualified vaccine to start soon; Unicef price is $2 per dose, private market price globally is $8-10; Initial volumes to be imported; India would need 83 mn doses a year

Over 400 million coronavirus vaccine doses administered in country: Govt

More than 46.38 lakh (46,38,106) vaccine doses were administered on Saturday, the report said

Offline retail revival depends on Covid vaccination coverage, says expert

Retail boom will be directly correlated to vaccination levels, Shoppers Stop MD and CEO Venu Nair said

Covid Response Plan for quick clearance of vaccines at airports: CBIC

Pandemic has posed unprecedented challenges disrupting global supply chains and slowing down economic activity

European nations impose incentives, penalties to boost Covid vaccine shots

Some business owners are uncomfortable with having to enforce the rules

Don't blame private sector

Vaccine distribution lags are because of state controls

Over 3 mn children in India missed out on first DTP-1 vax dose in 2020: WHO

Over 3 million children in India missed out on their first dose of diphtheria-tetanus-pertussis combined vaccine (DTP-1) in 2020, WHO said

Virus, variant and vaccines

The main worry is the price of vaccines, not production, says Sunita Narain

A bottleneck in the vaccine chain

Prosenjit Datta points to a possible crisis as the government moves to improve supplies of Covid vaccines: inadequate testing facilities to handle those volumes

Indian scientists working on developing mRNA vaccine technology get grant

Ignite Life Science Foundation has awarded its first grant award for "pandemic preparedness" research to a team of researchers at the Indian Institute of Science (Bengaluru)

Why Centre 'conspicuously silent' on Brazil's Covaxin controversy: Congress

The Congress Party on Friday cornered the central government over the Covaxin pricing controversy in Brazil and asked the Centre why it is "conspicuously silent" on the matter

Two doses of Covid-19 vaccine give 98% protection, says PGI study

The study, which didn't spe­cify the name of the vacc­ine, was conducted on Pun­jab police personnel

Covid-19 vaccine estimate of 2 bn doses aspirational, optimistic: Govt

Inoculation drive is a marathon, not a 100-metre sprint, says health ministry

World's 'first' DNA vaccine against coronavirus: All you need to know

If things go well, ZyCoV-D could be the first approved vaccine for adolescents. The vaccine also works against the Delta variant, claims the company

Covovax denied trials on children; no nod needed for Sputnik Light

The decision comes as a setback to SII, which had sought permission to start a pediatric clinical trial of Covovax

Decoded: Why Brazilian govt is under scrutiny over Bharat Biotech vaccine

The Brazilian media has reported that though Bharat Biotech initially quoted a price of $1.34 per dose, the Brazilian govt agreed to pay $15 per shot, having ignored Pfizer's offer at a lower price

Brazil suspends $324-mn Covid-19 vaccine deal with Bharat Biotech

The deal to buy 20 million doses of Bharat Biotech's Covaxin shot has become a headache for Bolsonaro after whistleblowers went public with alleged irregularities

Top headlines: India approves Moderna vaccine; Sebi announces reforms

Business Standard brings you the top news of the evening

Sanofi to invest 400 million euros in mRNA vaccines development

The mRNA technology has proven both effective and safe so far in the vaccine response to COVID-19, including in response to the virus' variants.